{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:29:29Z","timestamp":1792178969830,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The treatment of children with transfusion-dependent thalassemia (TDT) in Malaysia has progressed since 2005. This study provides an updated health-related quality of life (HRQoL) assessment for children with the disorder and the factors affecting the HRQoL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional HRQoL survey of Malaysian children with TDT was conducted using the PedsQL\u2122 4.0 Generic Core Scales. Patients with non-transfusion dependent thalassemia and other haemoglobinopathies were excluded. Parent-proxy and self-reported HRQoL scores were obtained using a multi-stage convenient sampling. The relationship between HRQoL scores and demographic factors were tested using association, correlation and regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 368 patients were recruited. The mean (SD) Total Summary Score (TSS) was 80.12(13.87). Predictors for a lower TSS was an increasing age group and the use of dual chelating agents (R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.057, F (4, 359)\u2009=\u20095.40, p\u2009=\u2009&lt;\u20090.001). The mean (SD) Physical Health Summary Score (PHSS) was 82.21 (16.82). Predictors of a higher PHSS score was being male, while predictors of a lower score was an increasing age group and parent-proxy reports(R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.075, F (5,358)\u2009=\u20095.80, p\u2009=\u2009&lt;\u20090.001). The mean (SD) Psychosocial Health Summary Score (PCHS) was 79.39 (14.81). Predictors for a lower PCHS was the use of dual chelating agents(R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.041, F (1, 362)\u2009=\u200915.60, p\u2009=\u2009&lt;\u20090.001). The school functioning score had the lowest mean (SD) score of 69.52(20.92) in the psychosocial dimension.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The HRQoL of TDT children in Malaysia has improved over the last decade owing to the better access in treatment. However, further effort is needed to improve the school functioning dimension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12955-020-01381-5","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T17:04:03Z","timestamp":1589475843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Health-related quality of life among children with transfusion-dependent thalassemia: A cross-sectional study in Malaysia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5629-9270","authenticated-orcid":false,"given":"Asrul Akmal","family":"Shafie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-7520","authenticated-orcid":false,"given":"Irwinder Kaur","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-5786","authenticated-orcid":false,"given":"Jacqueline Hui Yi","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-088X","authenticated-orcid":false,"given":"Noor Syahireen","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-3095","authenticated-orcid":false,"given":"Hishamshah Mohd","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3952-5368","authenticated-orcid":false,"given":"Hamidah","family":"Alias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"1381_CR1","volume-title":"Guidelines for the management of transfusion dependent thalassaemia (TDT): Thalassaemia international federation Nicosia, Cyprus","author":"M-D Cappellini","year":"2014","unstructured":"Cappellini M-D, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the management of transfusion dependent thalassaemia (TDT): Thalassaemia international federation Nicosia, Cyprus; 2014."},{"key":"1381_CR2","first-page":"1","volume-title":"Health technology assessment section MDD, editor","author":"HM Ibrahim","year":"2009","unstructured":"Ibrahim HM, Hassan A, George E, Goh AI, et al. Management of Transfusion Dependent Thalassaemia. In: Health technology assessment section MDD, editor. Putrajaya: CPG Secretariat; 2009. p. 1\u201321."},{"issue":"4","key":"1381_CR3","first-page":"397","volume":"56","author":"E George","year":"2001","unstructured":"George E. Beta-thalassemia major in Malaysia, an ongoing public health problem. Med J Malaysia. 2001;56(4):397\u2013400.","journal-title":"Med J Malaysia"},{"issue":"1","key":"1381_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1196\/annals.1345.035","volume":"1054","author":"P Telfer","year":"2005","unstructured":"Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in thalassemia. Ann N Y Acad Sci. 2005;1054(1):273\u201382.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1381_CR5","first-page":"326","volume":"66","author":"IA Wahab","year":"2011","unstructured":"Wahab IA, Naznin M, Nora MZ, Suzanah AR, Zulaiho M, Faszrul AR, et al. Thalassaemia: a study on the perception of patients and family members. Med J Malaysia. 2011;66(4):326\u201334.","journal-title":"Med J Malaysia"},{"issue":"3","key":"1381_CR6","first-page":"e99","volume":"162","author":"M Pennacchini","year":"2011","unstructured":"Pennacchini M, Bertolaso M, Elvira MM, De Marinis MG. A brief history of the quality of life: its use in medicine and in philosophy. Clin Ter. 2011;162(3):e99\u2013e103.","journal-title":"Clin Ter"},{"key":"1381_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1477-7525-4-39","volume":"4","author":"A Ismail","year":"2006","unstructured":"Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes. 2006;4:39.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"1381_CR8","first-page":"373","volume":"42","author":"M Ismail","year":"2013","unstructured":"Ismail M, Chun CY, Shahar S, Manaf ZA, Rajikan R, Yusoff NAM, et al. Quality of life among thalassaemia children, adolescent and their caregivers. Sains Malaysiana. 2013;42(3):373\u201380.","journal-title":"Sains Malaysiana"},{"issue":"2","key":"1381_CR9","first-page":"1","volume":"2","author":"S Sazlina","year":"2015","unstructured":"Sazlina S, Asauji Y, Juni MH. Predictors of health related quality of life among children and adolescents with beta thalassemia in three hospitals in Malaysia: a cross sectional study. Int J Public Health Clin Sci. 2015;2(2):1\u201312.","journal-title":"Int J Public Health Clin Sci"},{"issue":"Suppl. 7","key":"1381_CR10","first-page":"S65","volume":"93","author":"PSW Surapolchai","year":"2010","unstructured":"Surapolchai PSW, Sinlapamongkolkul P, Udomsubpayakul U. Biopsychosocial Predictors of Health-Related Quality of Life in Children with Thalassemia in Thammasat University Hospital. J Med Assoc THai. 2010;93(Suppl. 7):S65\u201375.","journal-title":"J Med Assoc THai"},{"issue":"1","key":"1381_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2326-10-1","volume":"10","author":"M Thavorncharoensap","year":"2010","unstructured":"Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol B-O. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Hematology. 2010;10(1):1.","journal-title":"BMC Hematology"},{"issue":"4","key":"1381_CR12","first-page":"951","volume":"42","author":"K Torcharus","year":"2011","unstructured":"Torcharus K, Pankaew T. Health-related quality of life in Thai thalassemic children treated with iron chelation. Southeast Asian J Trop Med Public Health. 2011;42(4):951.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"1381_CR13","doi-asserted-by":"crossref","unstructured":"Chordiya K, Katewa V, Sharma P, Deopa B, Katewa S. Quality of life (QoL) and the factors affecting it in transfusion-dependent Thalassemic children. Indian J Pediatr. 2018.","DOI":"10.1007\/s12098-018-2697-x"},{"issue":"10","key":"1381_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12098-014-1670-6","volume":"82","author":"R Saha","year":"2015","unstructured":"Saha R, Misra R, Saha I. Health related quality of life and its predictors among Bengali Thalassemic children admitted to a tertiary care hospital. Indian J Pediatr. 2015;82(10):909\u201316.","journal-title":"Indian J Pediatr"},{"issue":"8","key":"1381_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s12098-007-0127-6","volume":"74","author":"D Shaligram","year":"2007","unstructured":"Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr. 2007;74(8):727\u201330.","journal-title":"Indian J Pediatr"},{"issue":"7","key":"1381_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/MPH.0000000000000663","volume":"38","author":"HA-I Abdul-Zahra","year":"2016","unstructured":"Abdul-Zahra HA-I, Hassan MK, Ahmed BA. Health-related quality of life in children and adolescents with \u03b2-thalassemia major on different Iron Chelators in Basra, Iraq. J Pediatr Hematol Oncol. 2016;38(7):503\u201311.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"1381_CR17","first-page":"57","volume":"4","author":"S Ansari","year":"2014","unstructured":"Ansari S, Baghersalimi A, Azarkeivan A, Nojomi M, Rad AH. Quality of life in patients with thalassemia major. Iran J Pediatr Hematol Oncol. 2014;4(2):57.","journal-title":"Iran J Pediatr Hematol Oncol"},{"issue":"1","key":"1381_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2326-12-6","volume":"12","author":"G Caocci","year":"2012","unstructured":"Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E, et al. Health related quality of life in middle eastern children with beta-thalassemia. BMC Blood Disord. 2012;12(1):6.","journal-title":"BMC Blood Disord"},{"issue":"4","key":"1381_CR19","first-page":"224","volume":"10","author":"M Seyedifar","year":"2016","unstructured":"Seyedifar M, Dorkoosh FA, Hamidieh AA, Naderi M, Karami H, Karimi M, et al. Health-related quality of life and health utility values in Beta thalassemia major patients receiving different types of Iron Chelators in Iran. Int J Hematol Oncol Stem Cell Res. 2016;10(4):224\u201331.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"2","key":"1381_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11136-018-1986-1","volume":"28","author":"M Arian","year":"2019","unstructured":"Arian M, Mirmohammadkhani M, Ghorbani R, Soleimani M. Health-related quality of life (HRQoL) in beta-thalassemia major (\u03b2-TM) patients assessed by 36-item short form health survey (SF-36): a meta-analysis. Qual Life Res. 2019;28(2):321\u201334.","journal-title":"Qual Life Res"},{"issue":"1","key":"1381_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1524-4733.2004.71273.x","volume":"7","author":"LS Matza","year":"2004","unstructured":"Matza LS, Swensen AR, Flood EM, Secnik K, Leidy NK. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health. 2004;7(1):79\u201392.","journal-title":"Value Health"},{"issue":"6","key":"1381_CR22","first-page":"537","volume":"10","author":"NF Azman","year":"2016","unstructured":"Azman NF, Abdullah W-Z, Mohamad N, Bahar R, Johan MF, Diana R, et al. Practice of iron chelation therapy for transfusion-dependent thalassemia in Southeast Asia. Asian Biomed. 2016;10(6):537\u201347.","journal-title":"Asian Biomed"},{"key":"1381_CR23","volume-title":"RM40 mil to treat 600,000 victims of thalassaemia. The Star Online","author":"S T","year":"2005","unstructured":"S T. RM40 mil to treat 600,000 victims of thalassaemia. The Star Online. 2005."},{"key":"1381_CR24","unstructured":"New drug to treat thalassemia [Newspaper Article]. The Star; 2012 [6 June 2019]. Available from: https:\/\/www.thestar.com.my\/news\/nation\/2012\/05\/13\/new-drug-to-treat-thalassemia."},{"key":"1381_CR25","first-page":"9","volume":"1","author":"L Naing","year":"2006","unstructured":"Naing L, Winn T, Rusli B. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006;1:9\u201314.","journal-title":"Arch Orofac Sci"},{"issue":"8","key":"1381_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL\u2122 4.0: reliability and validity of the pediatric quality of life inventory\u2122 version 4.0 generic Core scales in healthy and patient populations. Med Care. 2001;39(8):800\u201312.","journal-title":"Med Care"},{"key":"1381_CR27","unstructured":"Varni JW. The PedsQL: About the Model 1998-2018 [cited 13.10.2018]. [Available from: http:\/\/www.pedsql.org\/about_pedsql.html."},{"issue":"1","key":"1381_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/pbc.23125","volume":"57","author":"A Hamidah","year":"2011","unstructured":"Hamidah A, Wong CY, Tamil AM, Zarina LA, Zulkifli ZS, Jamal R. Health-related quality of life (HRQOL) among pediatric leukemia patients in Malaysia. Pediatr Blood Cancer. 2011;57(1):105\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"1381_CR29","volume-title":"Stata Statistical Software: Release 13","author":"StataCorp","year":"2013","unstructured":"StataCorp. Stata Statistical Software: Release 13. College Station: StataCorp LP; 2013."},{"key":"1381_CR30","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","volume-title":"Statistical power analysis for the behavioral sciences: Routledge","author":"J Cohen","year":"2013","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences: Routledge; 2013."},{"issue":"1","key":"1381_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12955-018-0893-z","volume":"16","author":"GLA Hakeem","year":"2018","unstructured":"Hakeem GLA, Mousa SO, Moustafa AN, Mahgoob MH, Hassan EE. Health-related quality of life in pediatric and adolescent patients with transfusion-dependent ss-thalassemia in upper Egypt (single center study). Health Qual Life Outcomes. 2018;16(1):59.","journal-title":"Health Qual Life Outcomes"},{"key":"1381_CR32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3633.3633","volume-title":"Factors impacting quality of life in thalassemia patients; results from the Intercontinenthal collaborative study","author":"A Amid","year":"2016","unstructured":"Amid A, Leroux R, Merelles-Pulcini M, Yassobi S, Saliba AN, Ward R, et al. Factors impacting quality of life in thalassemia patients; results from the Intercontinenthal collaborative study. Am Soc Hematology; 2016."},{"issue":"1","key":"1381_CR33","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1186\/s40064-016-3568-4","volume":"5","author":"N Dhirar","year":"2016","unstructured":"Dhirar N, Khandekar J, Bachani D, Mahto D. Thalassemia major: how do we improve quality of life? SpringerPlus. 2016;5(1):1895.","journal-title":"SpringerPlus."},{"issue":"4","key":"1381_CR34","first-page":"326","volume":"66","author":"AW Jantan","year":"2011","unstructured":"Jantan AW, Muhammad SA, Mat Zain N, Abdul Rahman S, Mohamed Z, Rahim A, et al. Thalassaemia: a study on the perception of patients and family members. Med J Malays. 2011;66(4):326\u201334.","journal-title":"Med J Malays"},{"issue":"5","key":"1381_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/08880018.2015.1033795","volume":"32","author":"N Boonchooduang","year":"2015","unstructured":"Boonchooduang N, Louthrenoo O, Choeyprasert W, Charoenkwan P. Health-related quality of life in adolescents with thalassemia. Pediatr Hematol Oncol. 2015;32(5):341\u20138.","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"1381_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MPH.0000000000000790","volume":"39","author":"G Tuysuz","year":"2017","unstructured":"Tuysuz G, Tayfun F. Health-related quality of life and its predictors among transfusion-dependent thalassemia patients. J Pediatr Hematol Oncol. 2017;39(5):332\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"1381_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1477-7525-4-73","volume":"4","author":"L Abetz","year":"2006","unstructured":"Abetz L, Baladi J-F, Jones P, Rofail D. The impact of iron overload and its treatment on quality of life: results from a literature review. Health Qual Life Outcomes. 2006;4(1):73.","journal-title":"Health Qual Life Outcomes"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01381-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-020-01381-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01381-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:35:48Z","timestamp":1620934548000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-020-01381-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1381"],"URL":"https:\/\/doi.org\/10.1186\/s12955-020-01381-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20369\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20369\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20369\/v1","asserted-by":"object"}]},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was registered with the Malaysian National Medical Research Registry (NMRR -17-2614-38966). This study was also approved by the Malaysian Research and Ethics Committee. Prior to each interview, written consents and assents were obtained from both caregivers & patients who were willing to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Asrul Akmal Shafie and Hishamshah Mohd Ibrahim were engaged by Novartis for speaking engagements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}